Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.
about
Channelopathy pathogenesis in autism spectrum disordersA mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by Gprin1 regulates growth.Systems Pharmacology Based Study of the Molecular Mechanism of SiNiSan Formula for Application in Nervous and Mental Diseases.Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Gene discovery and functional assessment of rare copy-number variants in neurodevelopmental disorders.Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics.Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.Excellent outcome with de novo 15q13.3 microdeletion causing infantile spasms-A further patient
P2860
Q26864726-5412A6E1-FA37-4EC5-B376-EB51B57784A7Q27324628-5EF4EE70-DC17-4C23-8A32-2FDA493E3DEFQ30381001-42E9A8DF-F0C5-437D-A086-5495185076F5Q30394589-E851EAA6-2613-4CCE-85E3-3943391D6056Q30407039-B9D4EDD3-D76D-4C6F-9A9C-9E573E9AE55DQ34004330-FE4AD04F-53FA-47D4-870E-2BA75C481355Q34060159-832B642E-BCA0-4E8B-BB6A-79A6F7D0A867Q35834299-C741CE2D-9B41-4ED5-A831-44CB4B65D0F4Q37531907-60B2BE97-E3B7-418A-BCBE-32CE6D5AE8A2Q37561567-23862686-672F-48B3-ABBB-97D363214379Q38066550-B51924EB-5828-43BC-9311-19D6C3FDEE80Q38478012-9FE44D95-E7A8-4C20-8480-6086FAEA25F1Q38767128-6677F88B-76E3-491B-96D5-6FE6BAB2D326Q45874331-C3594B78-4EBC-4258-91BE-DC6322D5C901Q50209842-D67FAF92-DE26-4027-B637-9E569C605C58Q57700005-832E48F7-279A-4086-B913-D4F682D525AF
P2860
Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@ast
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@en
type
label
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@ast
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@en
prefLabel
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@ast
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@en
P2093
P2860
P1433
P1476
Reduced Chrna7 expression in m ...... for neuropsychiatric diseases.
@en
P2093
J C Yonchek
K E Stevens
P U Teschke
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2012.01.033
P407
P577
2012-01-25T00:00:00Z